GSK PLC - London-based pharmaceutical company - Starts on Wednesday the second tranche of its previously announced £2.0 billion share buyback programme. The new tranche, worth up to £450.0 million, follows the completion of a first tranche of £700.0 million on Tuesday. Merrill Lynch International will run the second tranche, after Citigroup Global Markets Ltd ran the first. It will be completed by September 19. Shares bought will be held in treasury.

Current stock price in London: 1,481.50 pence

12-month change: down 8.3%

Copyright 2025 Alliance News Ltd. All Rights Reserved.